Epidemiologic data indicate that shorter sleep duration (≤5 hours per night) is associated with lower bone mineral density in postmenopausal women.
In a meta-analysis, researchers aimed to explore the association between denosumab and romosozumab and cardiovascular risk in patients with primary osteoporosis.
In this post hoc analysis, researchers evaluated the efficacy and safety of abaloparatide followed by alendronate vs placebo followed by alendronate in a subgroup of patients with osteoarthritis.
Elevated calcium levels may lead to suboptimal growth of bone, according to the study’s findings.
A second course of romosozumab led to either gains in or maintenance of bone mineral density in postmenopausal women who were 12 months off treatment or transitioning from denosumab.
Nonbisphosphonates, including denosumab, raloxifene, romosozumab, and teriparatide, significantly reduce vertebral fractures and benefit femoral neck bone mineral density compared with placebo.
Investigators evaluated the effect of magnetic resonance imaging baseline inflammation on changes in bone mineral density over the course of 5 years in patients with early spondyloarthritis.
In patients with osteoporosis, treatment preference varies but is not related to specific patient characteristics.
Risperidone treatment may not be associated with an increased risk for osteoporosis-related fractures compared with other atypical antipsychotic medications, according to study results published in Acta Psychiatrica Scandinavica. Researchers conducted a nationwide cohort study comparing the risk for osteoporosis-related fractures in patients treated with risperidone vs other atypical and typical antipsychotic medications. Investigators specifically evaluated…
Diagnosis of osteoporosis based on QCT analysis is more common in patients with diabetes and impaired glucose tolerance compared with patients with normal glucose tolerance.
In patients who underwent Roux-en-Y gastric bypass, bone material strength index was improved 1 year after surgery despite an increase in bone turnover and lower overall areal bone mineral density.